Skip to main content
. Author manuscript; available in PMC: 2013 Mar 3.
Published in final edited form as: Biomaterials. 2012 Apr 1;33(18):4752–4761. doi: 10.1016/j.biomaterials.2012.03.023

Fig. 2.

Fig. 2

The effect of treatments on IL-12 concentrations in serum (A) and IL-6 concentrations in serum (B) in animals, Control group – animals gavaged with empty alginatechitosan (AC) microcapsules suspended in PBS, Treatment group – animals gavaged with AC microencapsulated lipidoid and oxaliplatin nanoparticles suspended in PBS. Data represent the mean ± SD of concentration levels per group. Asterisks: statistical differences (p < .05) when compared to control.